Key Documents
Leonore A. Herzenberg
- Professor (Research), Genetics
- Member, Cancer Center
Contact Information
- Academic Offices
Personal Information Email LEEHERZ@DARWIN.stanford.eduAdministrative Contact John Mantovani Administrator to the Herzenbergs Email johnjm@stanford.edu Tel Work 650 723-5054
Honors and Awards
- Heroic Achievement in Information Technology, The ComputerWorld Smithsonian Award (June 4, 1996)
- Symposium Chair & Speaker, International Congress of Immunology (1986)
- Member, Genetics Society of America (0)
- Member, American Association of Immunologists (0)
- Eleanor Roosevelt Cancer Fellowship,, American Cancer Society (1986)
Professional Education
- D.Sc-equiv., Universioty Paris V Sorbonne Immunolgy (1981)
Postdoctoral Advisees
Graduate & Fellowship Program Affiliations
Web Site Links
Research Interests
We maintain jointly functioning laboratory groups. Our focus is on gene regulation in the immune system, development and function of B cell subpopulations, and applications of Fluorescence-Activated Cell Sorting(FACS).
We have been interested for many years in the genetics and development of the immune system in mice. A major tool we have developed to aid us in this work is the Fluorescence-Activated Cell Sorter(FACS), which permits analysis and sorting of viable cells very rapidly on the basis of fluorescence marking. Recently we have devised a method to study gene regulation at the individual cell level using the FACS and a fluorogenic substrate for E. coli lac Z-encoded ß-galactosidase (ß-gal).
Current Studies include:
1) A new population of B cells, Ly-1B, which follow different rules of differentiation than conventional B-cells, have different V gene repertoires and provide a model for autoimmune diseases and chronic lymphocytic leukemia (CLL).
2) Regulation of lymphocyte development, especially B and T cell development.
3) Cis and trans-acting elements regulating the variation of ß-gal expresstion in populations of lymphoid cells infected with lacZ recombinant retroviruses in which various viral and cellular promoters "drive" lacZ.
4) Cell lineage studies using introduced lacZ rDNA retroviruses as cellular markers with the FACS / b-gal assay.
5) The cell biology of AIDS in model systems including activation of b-gal expression in cells carrying the lacZ gene under control of HIV promoters and regulatory elements.
6) What transgenic mice can and can't tell us about cellular and molecular development of the immune system.
In addition to improving FACS operations with a dedicated group of engineers, computer scientists, programmers, and a physicist, opportunities always exist for technologically oriented students interested in molecular biology and immunology.
Publications
- Nat Immunol. 2007; (8): 783-6
- Nat Immunol. 2006; (7): 681-5
- Nat Immunol. 2006; (3): 225-6
- Annu Rev Immunol. 2004; 1-31
- J Invest Dermatol. 2008; (8): 1969-76
- Proc Natl Acad Sci U S A. 2008; (13): 5195-200
- Rev Mal Respir. 2007; (8): 955-64
- AMIA Annu Symp Proc. 2007; 1177
- Curr Opin Pharmacol. 2007; (4): 355-9
- Proteomics. 2007; (2): 180-4
- Blood. 2007; (10): 4191-9
- Curr Opin Immunol. 2007; (2): 150-5
- Proc Natl Acad Sci U S A. 2007; (11): 4547-52
- Proc Natl Acad Sci U S A. 2007; (11): 4542-6
- Clin Lab Med. 2007; (3): 453-68, v
- Proc Natl Acad Sci U S A. 2006; (12): 4628-33
- Proc Natl Acad Sci U S A. 2006; (16): 6293-8
- Cancer Res. 2006; (13): 6598-605
- Arch Biochem Biophys. 2005; (1): 26-32
- Transplantation. 2005; (1): 134-9
- Proc Natl Acad Sci U S A. 2005; (10): 3756-9
- Genetics. 2005; (1): 215-29
- Proc Natl Acad Sci U S A. 2004; (9): 2912-7
- Proc Natl Acad Sci U S A. 2004; (11): 3898-902
- Methods Mol Biol. 2004; 37-58
- Clin Immunol. 2004; (3): 277-83
- J Immunol. 2004; (3): 1637-45
- Nat Immunol. 2003; (11): 1083-92
- Proc Natl Acad Sci U S A. 2003; (7): 4001-5
- Clin Chem. 2002; (10): 1819-27
- Proc Natl Acad Sci U S A. 2002; (4): 2270-4
- Mol Immunol. 2002; (10): 773-80
- Proc Natl Acad Sci U S A. 2002; (5): 3007-12
- Proc Natl Acad Sci U S A. 2001; (20): 11644-9
- Cytometry. 2001; (1): 24-9
- BMC Mol Biol. 2001; 5
- Proc Natl Acad Sci U S A. 2001; (5): 2688-93
- Chem Biol. 2001; (1): 71-80
- Immunol Rev. 2000; 9-22
- Eur J Clin Invest. 2000; (10): 915-29
- J Immunol. 2000; (9): 4822-30
- Proc Natl Acad Sci U S A. 2000; (26): 14766-71
- Proc Natl Acad Sci U S A. 2000; (6): 2680-5
- Curr Top Microbiol Immunol. 2000; 3-13
- Immunol Today. 2000; (8): 383-90
- J Exp Med. 2000; (2): 271-80
- Proc Natl Acad Sci U S A. 2000; (9): 4766-71
- Curr Top Microbiol Immunol. 2000; 163-9
- J Biol Chem. 1999; (2): 657-65
- Proc Natl Acad Sci U S A. 1999; (5): 2250-5
- Proc Natl Acad Sci U S A. 1999; (5): 2262-7
- Anal Biochem. 1999; (1): 107-9
- Cytometry. 1999; (1): 36-45
- Int Immunol. 1999; (11): 1801-10
- Cytometry. 1998; (4): 435-44
- J Immunol. 1998; (4): 1710-7
- Semin Immunol. 1997; (6): 389-96
- Blood. 1997; (9): 3662-72
- J Exp Med. 1997; (8): 1365-72
- Int Immunol. 1997; (6): 835-41
- Int Immunol. 1997; (5): 689-702
- Blood. 1997; (9): 3412-20
- Ann N Y Acad Sci. 1997; 484-8
- J Clin Invest. 1997; (7): 1555-64
- Proc Natl Acad Sci U S A. 1997; (5): 1967-72
- J Immunol. 1997; (3): 1175-86
- Cytometry. 1996; (3): 191-7
- Cytometry. 1996; (4): 321-9
- Int Immunol. 1996; (8): 1311-7
- Proc Natl Acad Sci U S A. 1996; (16): 8508-11
- Proc Natl Acad Sci U S A. 1996; (22): 12376-81
- Proc Natl Acad Sci U S A. 1996; (9): 3947-52
- Int Immunol. 1996; (4): 603-11
- Int Immunol. 1996; (1): 1-11
- Cytometry. 1995; (2): 187-96
- Ann N Y Acad Sci. 1995; 224-7
- Int Immunol. 1995; (1): 55-68
- J Reprod Immunol. 1995; (1): 53-60
- J Clin Invest. 1995; (5): 2054-60
- Immunity. 1995; (2): 239-50
- J Exp Med. 1995; (6): 2029-36
- J Clin Invest. 1995; (5): 2061-6
- AIDS Res Hum Retroviruses. 1994; (8): 961-7
- Cytometry. 1994; (4): 357-63
- Proc Natl Acad Sci U S A. 1994; (24): 11527-31
- Proc Natl Acad Sci U S A. 1994; (9): 3619-22
- Annu Rev Immunol. 1993; 501-38
- Immunol Today. 1993; (2): 79-83; discussion 88-90
- Ann N Y Acad Sci. 1993; 113-25
- AIDS Res Hum Retroviruses. 1993; (4): 299-306
- Proc Natl Acad Sci U S A. 1993; (17): 8194-8
- Pharmacology. 1993; (3): 121-9
- Ann N Y Acad Sci. 1992; 33-43
- Ann N Y Acad Sci. 1992; 453-63
- Ann N Y Acad Sci. 1992; 168-9
- Ann N Y Acad Sci. 1992; 1-9
- J Acquir Immune Defic Syndr. 1992; (6): 627-32
- Proc Natl Acad Sci U S A. 1992; (8): 3320-4
- Lancet. 1992; (8798): 909-12
- AIDS Res Hum Retroviruses. 1992; (2): 209-17
- Int Immunol. 1992; (2): 243-52
- Immunology. 1992; (1): 95-102
- Int Immunol. 1991; (9): 933-7
- Int Immunol. 1991; (11): 1117-27
- AIDS Res Hum Retroviruses. 1991; (6): 563-7
- Cytometry. 1991; (4): 291-301
- Adv Exp Med Biol. 1991; 187-200
- Science. 1991; (4989): 81-5
- Proc Natl Acad Sci U S A. 1990; (24): 9943-7
- EMBO J. 1990; (13): 4425-33
- Genes Dev. 1990; (10): 1823-34
- EMBO J. 1990; (7): 2117-24
- J Immunol. 1990; (5): 1705-10
- Arthritis Rheum. 1990; (4): 553-62
- Proc Natl Acad Sci U S A. 1990; (12): 4884-8
- Nucleic Acids Res. 1990; (11): 3255-60
- Eur J Immunol. 1990; (7): 1527-34
- Res Immunol. 1989 Mar-Apr; (3): 337-8; discussion 339-45
- Immunol Invest. 1989 Jan-May; (1-4): 47-58
- Immunol Suppl. 1989; 74-8; discussion 79
- Eur J Immunol. 1989; (3): 501-6
- Cell. 1989; (6): 953-4
- J Autoimmun. 1989; 225-31
- Int Immunol. 1989; (1): 75-84
- Cold Spring Harb Symp Quant Biol. 1989; 219-25
- Cold Spring Harb Symp Quant Biol. 1989; 767-76
- EMBO J. 1988; (12): 3705-10
- Proc Natl Acad Sci U S A. 1988; (22): 8391-4
- Eur J Immunol. 1988; (11): 1819-26
- Proc Natl Acad Sci U S A. 1988; (19): 7312-6
- EMBO J. 1988; (7): 1989-94
- Proc Natl Acad Sci U S A. 1988; (10): 3546-50
- Proc Natl Acad Sci U S A. 1988; (8): 2603-7
- J Immunol. 1987; (11): 3660-4
- Vet Immunol Immunopathol. 1987; (1-4): 291-302
- Proc Natl Acad Sci U S A. 1963; (5): 592-8